The realization of the therapeutic potential of monoclonal antibodies will depend on the efficient generation and maintenance of hybridomas. At a recent workshop on the Stability and Viability of Antibody-Producing Cell Lines it was clear that there are still large gaps in the knowledge needed to achieve that aim.
|Original language||English (US)|
|Number of pages||2|
|Journal||Trends in Immunology|
|Publication status||Published - Dec 1 1987|
ASJC Scopus subject areas
- Immunology and Allergy